NASDAQ : MASS

908 Devices Inc.

$7.35 USD

-$0.06 (-0.81%)

Volume
270.36K
Average Volume
288.3K
Market Capitalization
$301.55M
P/E Ratio
-7.50
Dividend Yield
0.00%
Price Target
Year High
$9.34
Year Low
$5.03
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$3.58
Source Headline
Masivo Confirms High-Grade Gold-Copper Mineralization Beneath Historic Boston Mine with 45 ft. of 3.25% Cu Equivalent Including 5ft.

Vancouver, British Columbia--(Newsfile Corp. - July 15, 2026) - Masivo Silver Corp. (TSXV: MASS) (OTC Pink: GNYPF) (FSE: R74) is pleased to report drill results from its Boston Mine Project in northeastern Nevada, confirming the continuation of high-grade gold, silver and copper mineralization beneath the historic underground workings. Seven drill holes were completed testing surface showings and high grade underground samples from the upper level of the mine.

newsfilecorp.com - 2026-07-15 10:38:00

Volatus Aerospace to Showcase Multi-Domain Capabilities at MASS 2026

Supporting Canada's Arctic sovereignty and maritime security through integrated, mission-ready aerospace, autonomy and intelligence solutions Supporting Canada's Arctic sovereignty and maritime security through integrated, mission-ready aerospace, autonomy and intelligence solutions

globenewswire.com - 2026-07-09 07:30:00

908 Devices (MASS) Upgraded to Buy: Here's Why

908 Devices (MASS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

zacks.com - 2026-06-04 13:01:13

908 Devices Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

BURLINGTON, Mass.--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, announced that on June 1, 2026, the Compensation Committee of its Board of Directors granted options to four new non-executive employees to purchase an aggregate of 179,912 shares of 908 Devices' common stock. The options were granted as a material inducement to employment with 908 D.

businesswire.com - 2026-06-02 16:30:00

908 Devices to Present at the 16th Annual East Coast IDEAS Investor Conference

BURLINGTON, Mass.--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, announced that CEO and Co-founder Kevin J. Knopp and CFO Joe Griffith will present and host investor meetings at the 16th Annual East Coast IDEAS Conference on Wednesday, June 10, 2026. The Company presentation is scheduled to begin at 8:35 a.m. Eastern Time. The presentation is webc.

businesswire.com - 2026-05-28 07:00:00

908 Devices Looking Better Now (Rating Upgrade)

908 Devices (MASS) delivered strong Q1 results, raising full-year revenue guidance after a strategic acquisition in narcotics detection. Adjusted gross margins improved nearly three percentage points to 57%, and operating cash flow turned positive. The company has a solid balance sheet with nearly $100 million in cash post-acquisition and is debt free, while trading at a reasonable valuation.

seekingalpha.com - 2026-05-18 01:31:14

908 Devices Inc. (MASS) Q1 2026 Earnings Call Transcript

908 Devices Inc. (MASS) Q1 2026 Earnings Call Transcript

seekingalpha.com - 2026-05-06 18:11:14

908 Devices Inc. (MASS) Reports Q1 Loss, Tops Revenue Estimates

908 Devices Inc. (MASS) came out with a quarterly loss of $0.15 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.22 per share a year ago.

zacks.com - 2026-05-06 10:06:12

908 Devices Reports First Quarter 2026 Financial Results and Raises 2026 Revenue Outlook

BURLINGTON, Mass.--(BUSINESS WIRE)-- #ChemicalID--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today reported financial results for the quarter ended March 31, 2026. “We delivered a strong start to 2026, achieving 14% revenue growth and meaningful margin expansion,” said Kevin J. Knopp, CEO and Co-founder. “We are also excited to announce the acquisition of NIRLAB AG, a strate.

businesswire.com - 2026-05-06 07:30:00

908 Devices Acquires NIRLAB AG, Expanding Its Narcotics Detection Portfolio

BURLINGTON, Mass.--(BUSINESS WIRE)-- #LawEnforcement--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces that it has completed the acquisition of NIRLAB AG, a privately held company based in Lausanne, Switzerland. The company delivers AI-powered, cloud-connected near-infrared (NIR) spectroscopy to perform handheld chemical analysis of narcotics in seconds. This acquisition expands 908 Devices' analytical portfolio and strengthens its leadership in narcot.

businesswire.com - 2026-05-06 07:00:00

908 Devices to Report First Quarter 2026 Financial Results on May 6, 2026

BURLINGTON, Mass.--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, announced it will report financial results for the first quarter 2026 before market open on Wednesday, May 6, 2026. Company management will webcast a corresponding conference call beginning at 8:30 a.m. Eastern Time. Live audio of the webcast will be available on the “Investors” sect.

businesswire.com - 2026-05-01 08:30:00

908 Devices Appoints Kola Otitoju as Chief Business & Strategy Officer and Announces an Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

BURLINGTON, Mass.--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces the appointment of Kola Otitoju as its Chief Business & Strategy Officer, a newly created executive position. Mr. Otitoju will oversee product and corporate strategy, business development, mergers and acquisitions, and partnership initiatives as 908 Devices expands its market presence across public health, safety, and defense-tech applications. Mr.

businesswire.com - 2026-04-21 17:00:00

Get MASS Insider Trade Alerts

MASS Price Target Summary

Last Month

0 analysts

Last Quarter

0 analysts

Last Year

0 analysts

All Time

0 analysts

MASS Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2025-08-05 Leerink Partners Upgrade Market Perform Outperform
2025-01-15 Stephens & Co. Maintain Overweight Overweight
2024-11-13 Stifel Maintain Buy Buy
2024-11-13 Leerink Partners Downgrade Outperform Market Perform
2024-10-17 Leerink Partners Maintain Outperform Outperform
2024-05-13 Stephens & Co. Maintain Overweight Overweight
2023-09-25 Stephens & Co. Maintain Overweight Overweight
2023-02-07 Stephens & Co. Maintain Overweight Overweight
2023-01-06 SVB Leerink Maintain Outperform Outperform
2022-11-15 SVB Leerink Maintain Outperform Outperform
2022-03-08 SVB Leerink Maintain Outperform Outperform
2021-05-14 SVB Leerink Maintain Outperform Outperform
2021-01-12 SVB Leerink Maintain Outperform Outperform
2021-01-12 Cowen & Co. Maintain Outperform Outperform
2021-01-12 Stifel Maintain Buy Buy